Taysha Gene Therapies Inc
NASDAQ:TSHA
Balance Sheet
Balance Sheet Decomposition
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
Balance Sheet
Taysha Gene Therapies Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
251
|
149
|
88
|
144
|
139
|
|
| Cash Equivalents |
0
|
251
|
149
|
88
|
144
|
139
|
|
| Other Current Assets |
0
|
7
|
11
|
9
|
6
|
3
|
|
| Total Current Assets |
0
|
258
|
160
|
96
|
150
|
142
|
|
| PP&E Net |
0
|
0
|
51
|
26
|
20
|
16
|
|
| PP&E Gross |
0
|
0
|
51
|
26
|
20
|
16
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
3
|
4
|
|
| Other Long-Term Assets |
0
|
1
|
4
|
4
|
2
|
2
|
|
| Total Assets |
0
N/A
|
259
N/A
|
214
-17%
|
126
-41%
|
173
+37%
|
160
-7%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
2
|
22
|
11
|
6
|
4
|
|
| Accrued Liabilities |
0
|
5
|
30
|
18
|
11
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
34
|
19
|
11
|
|
| Total Current Liabilities |
0
|
7
|
52
|
63
|
37
|
26
|
|
| Long-Term Debt |
0
|
0
|
37
|
38
|
41
|
44
|
|
| Other Liabilities |
0
|
1
|
30
|
25
|
20
|
18
|
|
| Total Liabilities |
0
N/A
|
8
+3 700%
|
119
+1 461%
|
125
+6%
|
98
-22%
|
89
-9%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
61
|
236
|
401
|
513
|
602
|
|
| Additional Paid In Capital |
1
|
312
|
331
|
402
|
588
|
678
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
4
|
|
| Total Equity |
0
N/A
|
251
N/A
|
95
-62%
|
1
-99%
|
75
+8 226%
|
72
-5%
|
|
| Total Liabilities & Equity |
0
N/A
|
259
N/A
|
214
-17%
|
126
-41%
|
173
+37%
|
160
-7%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
35
|
35
|
39
|
63
|
187
|
205
|
|